Cite
Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.
MLA
Lompré, A. M., et al. “Efficient Transduction of Vascular Smooth Muscle Cells with a Translational AAV2.5 Vector: A New Perspective for in-Stent Restenosis Gene Therapy.” Gene Therapy, vol. 20, no. 9, Sept. 2013, pp. 901–12. EBSCOhost, https://doi.org/10.1038/gt.2013.13.
APA
Lompré, A.-M., Hadri, L., Merlet, E., Keuylian, Z., Mougenot, N., Karakikes, I., Chen, J., Atassi, F., Marchand, A., Blaise, R., Limon, I., McPhee, S. W. J., Samulski, R. J., Hajjar, R. J., & Lipskaia, L. (2013). Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy. Gene Therapy, 20(9), 901–912. https://doi.org/10.1038/gt.2013.13
Chicago
Lompré, A-M, L Hadri, E Merlet, Z Keuylian, N Mougenot, I Karakikes, J Chen, et al. 2013. “Efficient Transduction of Vascular Smooth Muscle Cells with a Translational AAV2.5 Vector: A New Perspective for in-Stent Restenosis Gene Therapy.” Gene Therapy 20 (9): 901–12. doi:10.1038/gt.2013.13.